tiprankstipranks
Advertisement
Advertisement
Galera Announces Obsidian Merger and $350M Financing
PremiumCompany AnnouncementsGalera Announces Obsidian Merger and $350M Financing
3M ago
Galera Therapeutics, Obsidian Therapeutics enter merger agreement
Premium
The Fly
Galera Therapeutics, Obsidian Therapeutics enter merger agreement
3M ago
Galera Therapeutics Announces Share Conversions and Warrant Exercise
Premium
Company Announcements
Galera Therapeutics Announces Share Conversions and Warrant Exercise
3M ago
Galera Therapeutics Sells Assets to Biossil Inc.
PremiumCompany AnnouncementsGalera Therapeutics Sells Assets to Biossil Inc.
9M ago
Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105M
Premium
The Fly
Biossil to acquire Galera’s dismutase mimetics portfolio for up to $105M
9M ago
Galera Therapeutics Sells Assets to Biossil Inc.
Premium
Company Announcements
Galera Therapeutics Sells Assets to Biossil Inc.
9M ago
UroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
PremiumThe FlyUroGen Pharma CFO Don Kim departs, Chris Degnan succeeds
2y ago
Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting
Premium
Company Announcements
Galera Therapeutics Announces Wind-Up and Special Stockholder Meeting
2y ago
Galera Therapeutics reports Q2 EPS (7c) vs. (48c) last year
Premium
The Fly
Galera Therapeutics reports Q2 EPS (7c) vs. (48c) last year
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100